Phlorotannins alleviate obesity and obesity-related disorders through several mechanisms, including inhibition of pancreatic lipase (see Section 3) and obstruction of adipocyte differentiation. Here, PNLIP is linked to obesity due to melanocortin 4 receptor deficiency.